Staphylococcus aureus lipoproteins promote abscess formation in mice, shielding bacteria from immune killing

Majd Mohammad1, Manli Na2, Zhicheng Hu2,3

  • 1Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. majd.mohammad@rheuma.gu.se.

Communications Biology
|March 31, 2021
PubMed

Insights

Staphylococcus aureus lipoproteins (Lpp) cause skin lesions and inflammation by recruiting immune cells. These lipoproteins promote bacterial survival in skin infections, suggesting an immune evasion strategy.

Area of Science:

  • Microbiology
  • Immunology
  • Dermatology

Background:

  • Staphylococcus aureus lipoproteins (Lpp) are key immune activators, but their role in skin infections is unclear.
  • Understanding Lpp's function is crucial for addressing S. aureus skin infections.

Purpose of the Study:

  • To investigate the role of Staphylococcus aureus lipoproteins (Lpp) in the pathogenesis of skin infections.
  • To elucidate the mechanisms by which Lpp contribute to S. aureus skin infections.

Main Methods:

  • Subcutaneous injection of S. aureus Lpp in mouse models.
  • Assessment of immune cell infiltration, lesion development, and bacterial load.
  • Evaluation of the roles of Lpp lipid moiety and host TLR2.
  • Analysis of hemostasis and the impact of leukocyte and fibrinogen depletion.

Main Results:

  • S. aureus Lpp induced skin lesions, neutrophil, and monocyte/macrophage infiltration, dependent on Lpp lipid moiety and host TLR2.
  • Lpp-deficient S. aureus strains showed reduced lesion size and bacterial loads, independent of TLR2.
  • Lpp expression promoted a hypercoagulable state in skin infections.
  • Leukocyte or fibrinogen depletion abrogated Lpp-induced skin lesions and bacterial burden.

Conclusions:

  • Staphylococcus aureus Lpp drive skin inflammation and abscess formation, aiding bacterial survival against innate immunity.
  • Lpp represent a significant bacterial immune evasion mechanism in skin infections.
  • Targeting Lpp could be a therapeutic strategy for S. aureus skin infections.